An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice-Reference-Cited by-同舟云学术

An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice

Author:

Rainone Michael¹²,Singh Isha¹²,Salo-Mullen Erin E.¹,Stadler Zsofia K.¹³,O’Reilly Eileen M.¹³⁴

Affiliation:

1. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

2. Department of Medicine, Mount Sinai St Luke’s and Mount Sinai West Hospitals, Icahn School of Medicine at Mount Sinai, New York, New York

3. David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York

4. Department of Medicine, Weill Cornell Medicine, New York, New York

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

Reference80 articles.

2. Cancer statistics, 2016.;Siegel;CA Cancer J Clin,2016

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Advances in Systemic Therapy in Pancreatic Cancer;Hematology/Oncology Clinics of North America;2024-06